中芯国际(0981.HK)拉升涨超10% 消息称已获美国成熟制程许可证
格隆汇12月31日丨继昨日下午拉升收涨11.96%后,中芯国际(0981.HK)今日再度大涨,盘中一度涨10.29%报22.5港元,A股目前涨超3%报58.55元。有媒体从行业求证得知,网传“中芯国际已获得美国成熟制程许可证”消息属实,据其分析表示:“向中芯国际开放成熟制程是时间问题;且在成熟制程方面,包括台积电等都有可能会被允许为国内芯片厂商代工。而在先进制程方面,或许国内依然面临‘卡脖子’的局面。”此前消息还称,美国针对成熟制程的许可是分批次发放,一次性发放4-5万片产能所用的设备。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.